The Net Margin of Lytix Biopharma AS (LYTIX.OL) is -846.64%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -846.64% |
| 2023-12-31 | -2202.38% |
| 2022-12-31 | -3979.35% |
| 2021-12-31 | -240250.00% |
| 2020-12-31 | -1402930.00% |
| 2019-12-31 | -10719.35% |
| 2018-12-31 | -18094.12% |
| 2017-12-31 | -5977.36% |